Logo image of AMLI

AMERICAN LITHIUM CORP (AMLI) Stock Fundamental Analysis

NASDAQ:AMLI - Nasdaq - CA0272592092 - Common Stock - Currency: USD

0.3752  +0.01 (+3.65%)

After market: 0.375 0 (-0.05%)

Fundamental Rating

2

Overall AMLI gets a fundamental rating of 2 out of 10. We evaluated AMLI against 150 industry peers in the Metals & Mining industry. AMLI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMLI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMLI has reported negative net income.
AMLI had a negative operating cash flow in the past year.
In the past 5 years AMLI always reported negative net income.
In the past 5 years AMLI always reported negative operating cash flow.
AMLI Yearly Net Income VS EBIT VS OCF VS FCFAMLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -19.16%, AMLI is not doing good in the industry: 77.70% of the companies in the same industry are doing better.
AMLI's Return On Equity of -19.52% is on the low side compared to the rest of the industry. AMLI is outperformed by 71.62% of its industry peers.
Industry RankSector Rank
ROA -19.16%
ROE -19.52%
ROIC N/A
ROA(3y)-17.84%
ROA(5y)-176.28%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A
AMLI Yearly ROA, ROE, ROICAMLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMLI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMLI Yearly Profit, Operating, Gross MarginsAMLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

AMLI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMLI has more shares outstanding
AMLI has a better debt/assets ratio than last year.
AMLI Yearly Shares OutstandingAMLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AMLI Yearly Total Debt VS Total AssetsAMLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 22.45 indicates that AMLI is not in any danger for bankruptcy at the moment.
The Altman-Z score of AMLI (22.45) is better than 87.16% of its industry peers.
AMLI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
AMLI's Debt to Equity ratio of 0.00 is amongst the best of the industry. AMLI outperforms 84.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 22.45
ROIC/WACCN/A
WACCN/A
AMLI Yearly LT Debt VS Equity VS FCFAMLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

AMLI has a Current Ratio of 4.22. This indicates that AMLI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.22, AMLI is doing good in the industry, outperforming 75.68% of the companies in the same industry.
A Quick Ratio of 4.22 indicates that AMLI has no problem at all paying its short term obligations.
With a decent Quick ratio value of 4.22, AMLI is doing good in the industry, outperforming 78.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 4.22
AMLI Yearly Current Assets VS Current LiabilitesAMLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.74% over the past year.
EPS 1Y (TTM)17.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AMLI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.88% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y46.32%
EPS Next 2Y24.25%
EPS Next 3Y12.88%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMLI Yearly Revenue VS EstimatesAMLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
AMLI Yearly EPS VS EstimatesAMLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMLI. In the last year negative earnings were reported.
Also next year AMLI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMLI Price Earnings VS Forward Price EarningsAMLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMLI Per share dataAMLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as AMLI's earnings are expected to grow with 12.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.25%
EPS Next 3Y12.88%

More info and screens

0

5. Dividend

5.1 Amount

AMLI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN LITHIUM CORP

NASDAQ:AMLI (12/27/2024, 8:03:06 PM)

After market: 0.375 0 (-0.05%)

0.3752

+0.01 (+3.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)N/A N/A
Inst Owners8.38%
Inst Owner ChangeN/A
Ins Owners4.23%
Ins Owner ChangeN/A
Market Cap81.77M
Analysts86.67
Price Target3.13 (734.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.1%
PT rev (3m)-4.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)44.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.16%
ROE -19.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.84%
ROA(5y)-176.28%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.22
Quick Ratio 4.22
Altman-Z 22.45
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2061.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.26%
EPS Next Y46.32%
EPS Next 2Y24.25%
EPS Next 3Y12.88%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.08%
EBIT Next 3Y-6.13%
EBIT Next 5YN/A
FCF growth 1Y26.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.39%
OCF growth 3YN/A
OCF growth 5YN/A